Vivoryon Therapeutics NV VVY.AS:Euronext Amsterdam

RT Quote | Exchange | EUR
Last | 9:35 AM CET
0.52quote price arrow down-0.009 (-1.70%)
Volume
84,435
52 week range
0.49 - 19.56
Loading...
  • Open0.524
  • Day High0.53
  • Day Low0.52
  • Prev Close0.529
  • 52 Week High19.56
  • 52 Week High Date05/09/23
  • 52 Week Low0.49
  • 52 Week Low Date03/11/24

Key Stats

  • Market Cap15.3M
  • Shares Out25.96M
  • 10 Day Average Volume242,870.33
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change-93.55

KEY STATS

  • Open0.524
  • Day High0.53
  • Day Low0.52
  • Prev Close0.529
  • 52 Week High19.56
  • 52 Week High Date05/09/23
  • 52 Week Low0.49
  • 52 Week Low Date03/11/24
  • Market Cap15.3M
  • Shares Out25.96M
  • 10 Day Average Volume242,870.33
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change-93.55

RATIOS/PROFITABILITY

  • EPS (TTM)-1.12
  • P/E (TTM)-0.47
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vivoryon Therapeutics NV

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vivoryon Therapeutics NV is a Germany-based clinical-stage biopharmaceutical company with focus on the research and development of new therapeutic products for the treatment of Alzheimer’s disease (AD) and other diseases with high medical need like Cancer and Fibrosis. The Company is developing a directed pipeline of product candidates with the project being a therapeutic approach for the treatment of AD. Its operations focus on the discovery and development of therapeutic...
Erich Platzer M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Frank Weber M.D.
Chief Executive Officer
Florian Schmid
Chief Financial Officer, Executive Director
Address
Weinbergweg 22
Halle
06120
Germany